We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Kiotech Intl | KIO | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 79.00 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 79.00 |
| Top Posts |
|---|
Posted at 01/1/2012 20:19 by ethelredtheready GROWTH INVESTORS..gives updates on biopharma companies including KIO |
Posted at 06/11/2011 21:04 by welsheagle From November's 'Company Refs', when price was 88p:-a/ Prospective PE ratio of 9.29 (based on one broker forecast recommending 'Corporate buy'). b/ Forecast growth in eps of 13.1%. c/ PEG ratio of 0.71. d/ Dividend of 2.8%. e/ Positive cash flow of 5.85p per share. f/ Net asset value per share of 80.5p. g/ Net cash per share of 19.3p. h/ Price to sales ratio of 0.75. i/ Turnover up from 0.16m to 21.6m in last six years. j/ Finance Director buying. All looks good |
Posted at 01/11/2011 07:52 by spekky Changing name.........Whilst I might agree that Kiotech doesn't give much of a clue to what the company business actually is,I'm not 100% that "Anpario" does either....I guess they already have approval from the main investors. I hope the new website reflects the "growing ambition" 'cos the current one is as dull as dishwater. |
Posted at 27/10/2011 09:41 by gerard j spekkyI don't want Bayer to come now - I first want this to achieve my target of £1.50-£1.60 and then a takeover at £2.00/£2.20. ...we even could have BASF counterbidding for KIO. Based on the latest results, I really think KIO has a long way to go, especially with the potential in China. |
Posted at 27/10/2011 09:10 by spekky Gerard JIt is a long term investment but I am convinced that Bayer will make an offer for KIO when/if Aquatice proves to be a success in Vietnam/Thailand. |
Posted at 18/10/2011 15:18 by tailgunner2 Well,heres a thing.......I had my broker call me this am......giving me the patter of routine call, but quickly got round to my KIO shares.....said how KIO several times have reached this price, but always seem to fall back...."maybe its time to sell to protect medium profit"....Yeah right....smacks to me of.....I want your shares coz this is taking off soon.......Hold tight guys.....I have. |
Posted at 14/9/2011 10:32 by spekky I assume that sooner or later,KIO will introduce an interim dividend.I'm not really expecting that tomorrow but it would be a way of attracting some further interest from the market.Progress in China and Brazil is essential and maybe some intimation that they are close to an acquisition. |
Posted at 18/7/2011 08:57 by spekky hitchinhonchoI think the only link to Cefas is on the Aquaculture side of the business.Cefas effectively own the intellectual property for Aquatice which as yet has not been commercialised.Last time I looked Cefas were shareholders in KIO.The agricultural R&D is carried out by Kiotechs own nutritionists/scient Edit...Seems as though the IFG tip might be having some effect,thanks for sharing. |
Posted at 12/4/2011 07:32 by welsheagle KIOTECH INTERNATIONAL PLC (AIM: KIO) ("Kiotech" or "the Company") Unaudited preliminary announcement of results for the year ended 31 December 2010 Kiotech International plc, the international supplier of natural high performance feed additives to enhance growth, health and sustainability in agriculture and aquaculture, is pleased to announce its preliminary results for the year ended 31 December 2010. The Group significantly increased its sales, profit and underlying earnings per share 2 over the previous year and also largely completed the integration of the Optivite Group, whose results are included for the full year. Key points: Financial -- 146% increase in underlying profit before tax and exceptional items1 of GBP1.9m (2009: GBP0.8m). -- 58% increase in underlying earnings per share 2 to 7.27p (2009: 4.60p). -- Sales advanced to GBP21.6m (2009: GBP11.0m). -- Cash balance of GBP3.5m at 31 December 2010 (2009: GBP5.0m). -- 74% increase in the proposed final dividend to 2.00 pence per share (2009: 1.15 pence). Key points: Operational -- Integration of Optivite largely complete with planned benefits being realised earlier than anticipated. -- Good performance from our international agriculture division. -- Purchase of Manton Wood production and head office site completed for GBP1.5m. Richard Rose, Chairman, commented: "This has been a very successful year during which the management team has worked hard to integrate the Optivite acquisition of September 2009. The benefits are being realised earlier than anticipated at the time of the acquisition. The success of the Optivite deal gives us the confidence to pursue similar opportunities in addition to developing and promoting our existing trading brands in global markets." Enquiries: |
Posted at 20/9/2010 13:42 by blenkinsop2 Speckky re your 656"If you have time (post KIO results) could you give an opinion here on whether you can see KIO's turnover/pbt at least matching that of EAH.Obviously I'm hoping both metrics will be on the up." I take it that you are referring to the P/E figure. I find it difficult to make any really convincing comments because it seems to me that this ratio is driven more by sentiment than by hard figures of company performance. EAH turnover to March 2010 £21.77M, pre-tax profit £2.00M (9.21%) KIO turnover to June 2010 10.96, pre-tax profit £0.74M (excluding one-off sale of Ultrabite) The KIO turnover for the first half of this year is almost exactly half EAH's for the whole of last year so the two companies appear to be comparable now on that basis. Profitability is lagging but this can be attributed to Optivite performance rather than KIO as a whole. So sorting out Optivite remains a key task for the management. However, whereas the P/E ratio for KIO is presently between 9 and 10, the P/E figure for EAH is over 70. This suggests to me that optimism for the future has driven the share price 7 times greater in relation to earnings for EAH than for KIO hence my comment about sentiment. One should note that the latest dividend for EAH was 1.24% and was covered by earnings to the tune of only 1.12 (i.e. very little retained within the business). By contrast the last dividend for KIO was a little higher at 1.33% but was covered about 4.2 times excluding the Ultrabite contribution (included, it brings the figure to 8.2 times). I am sure the share price would move up if the percentage dividend were to be increased. That at least would gear the share price to company performance rather than to sentiment. At some point, the potential for KIO will be recognised as it already has been for EAH but until then, this remains a good investment opportunity. I am not sure that EAH still is but am not a shareholder so any comment beyond that would be inappropriate. I comment on some of the messages above: - It is the shareholders and their sentiment that dictate share prices. The company performance, of course, affects the sentiment but not the share price directly. The only time that the company is directly involved is when the company raises money by selling shares. Thereafter they are traded without further reference to the company. However, many things affect sentiment amongst which are: good or bad results, takeover talk, bankruptcy talk, dividends and calls for finance. I am sure there are many others but these come immediately to mind. Finally, we are told in the KIO half yearly Report that although sales increased three-fold, profit only went up by one and a half times i.e. profitability was halved. KIO needs to slog away and bring the whole company up to Agil's level of performance, and then our investments will pay off handsomely. When? My best guess is around this time next year but there is still a lot for them to do. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
